$MASI
MASIMO CORP Stock $masi

$masi Overview Financials Valuation SEC Filings Company Website

2017 Q4 Form 10-K Financial Statement

#000093755618000019 Filed on February 28, 2018

Income Statement

Concept	2017 Q4	2017	2016 Q4
Revenue	$207.9M	$790.2M	$183.2M
YoY Change	13.5%	10.85%	20.07%
Cost Of Revenue	$69.30M	$268.2M	$57.50M
YoY Change	20.52%	14.35%	14.21%
Gross Profit	$138.7M	$522.0M	$124.3M
YoY Change	11.52%	9.13%	21.61%
Gross Profit Margin	66.68%	66.06%	67.86%
Selling, General & Admin	$77.80M	$273.0M	$57.85M
YoY Change	34.5%	7.19%	-2.96%
% of Gross Profit	56.11%	52.3%	46.53%
Research & Development	$16.10M	$65.23M	$15.67M
YoY Change	2.72%	13.08%	8.2%
% of Gross Profit	11.61%	12.5%	12.61%
Depreciation & Amortization	$5.700M	$20.06M	$4.300M
YoY Change	32.56%	19.29%	10.26%
% of Gross Profit	4.11%	3.84%	3.46%
Operating Expenses	$93.90M	$338.2M	$73.52M
YoY Change	27.72%	697.88%	-0.77%
Operating Profit	$44.73M	$183.8M	$310.4M
YoY Change	-85.59%	-57.84%	1003.06%
Interest Expense		$678.0K
YoY Change		-79.2%
% of Operating Profit		0.37%
Other Income/Expense, Net	$700.0K	$2.013M	-$546.0K
YoY Change	-228.21%	-182.87%	-48.0%
Pretax Income	$45.40M	$159.2M	$36.06M
YoY Change	25.91%	-52.19%	33.1%
Income Tax	-$24.80M	$61.01M	$8.285M
% Of Pretax Income	-54.63%	38.31%	22.98%
Net Earnings	-$7.735M	$124.8M	$215.3M
YoY Change	-103.59%	-59.89%	1014.06%
Net Earnings / Revenue	-3.72%	15.79%	117.52%
Basic Earnings Per Share	-$0.15	$2.42	$4.31
Diluted Earnings Per Share	-$0.15	$2.23	$3.97
COMMON SHARES
Basic Shares Outstanding	51.64M shares	51.52M shares	49.48M shares
Diluted Shares Outstanding		55.87M shares	53.57M shares

Balance Sheet

Concept	2017 Q4	2017	2016 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$315.3M	$315.3M	$126.0M
YoY Change	150.24%	3.04%	21.62%
Cash & Equivalents	$315.3M	$315.3M	$306.0M
Short-Term Investments
Other Short-Term Assets	$33.60M	$23.10M	$26.07M
YoY Change	28.91%	20.94%	-29.95%
Inventory	$92.26M	$92.30M	$72.54M
Prepaid Expenses	$10.52M		$13.05M
Receivables	$118.5M	$118.5M	$101.7M
Other Receivables	$10.60M	$10.60M	$7.800M
Total Short-Term Assets	$559.7M	$559.7M	$507.2M
YoY Change	10.34%	10.35%	70.47%
LONG-TERM ASSETS
Property, Plant & Equipment	$164.1M	$164.1M	$136.0M
YoY Change	20.66%	20.66%	5.78%
Goodwill	$20.62M		$19.78M
YoY Change	4.23%		-3.29%
Intangibles	$27.12M		$29.38M
YoY Change	-7.67%		5.35%
Long-Term Investments	$1.234M	$1.200M	$200.0K
YoY Change	517.0%
Other Assets	$4.668M	$132.7M	$9.223M
YoY Change	-49.39%	3.59%	-18.51%
Total Long-Term Assets	$345.7M	$345.7M	$313.3M
YoY Change	10.36%	10.34%	11.8%
TOTAL ASSETS
Total Short-Term Assets	$559.7M	$559.7M	$507.2M
Total Long-Term Assets	$345.7M	$345.7M	$313.3M
Total Assets	$905.4M	$905.4M	$820.5M
YoY Change	10.35%	10.35%	42.01%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$33.78M	$33.80M	$34.34M
YoY Change	-1.62%	8.68%	19.49%
Accrued Expenses	$2.924M	$53.20M	$28.27M
YoY Change	-89.66%	-28.78%	17.31%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due			$100.0K
YoY Change			0.0%
Total Short-Term Liabilities	$129.7M	$129.7M	$220.4M
YoY Change	-41.16%	-41.15%	97.15%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$152.5M
YoY Change	-100.0%		-19.78%
Other Long-Term Liabilities	$51.76M	$41.90M	$14.59M
YoY Change	254.82%	5.01%	98.68%
Total Long-Term Liabilities	$51.76M	$41.90M	$14.59M
YoY Change	254.82%	5.01%	98.68%
TOTAL LIABILITIES
Total Short-Term Liabilities	$129.7M	$129.7M	$220.4M
Total Long-Term Liabilities	$51.76M	$41.90M	$14.59M
Total Liabilities	$181.4M	$181.4M	$260.3M
YoY Change	-30.3%	-30.31%	-15.91%
SHAREHOLDERS EQUITY
Retained Earnings	$738.0M		$589.2M
YoY Change	25.24%		122.8%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)	$472.5M		$404.3M
YoY Change	16.88%		27.91%
Treasury Stock Shares	15.06M shares		15.06M shares
Shareholders Equity	$724.0M	$724.0M	$560.2M
YoY Change
Total Liabilities & Shareholders Equity	$905.4M	$905.4M	$820.5M
YoY Change	10.35%	10.35%	42.01%

Cashflow Statement

Concept	2017 Q4	2017	2016 Q4
OPERATING ACTIVITIES
Net Income	-$7.735M	$124.8M	$215.3M
YoY Change	-103.59%	-59.89%	1014.06%
Depreciation, Depletion And Amortization	$5.700M	$20.06M	$4.300M
YoY Change	32.56%	19.29%	10.26%
Cash From Operating Activities	$48.70M	$56.06M	$31.30M
YoY Change	55.59%	-86.62%	15.5%
INVESTING ACTIVITIES
Capital Expenditures	-$6.700M	$43.68M	-$5.600M
YoY Change	19.64%	121.67%	-66.47%
Acquisitions		$0.00
YoY Change		-100.0%
Other Investing Activities	$0.00	$1.145M	-$200.0K
YoY Change	-100.0%	50.07%
Cash From Investing Activities	-$6.700M	-$47.91M	-$5.800M
YoY Change	15.52%	89.25%	-65.27%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$66.27M
YoY Change		-2.85%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-17.10M	-$4.138M	-15.40M
YoY Change	11.04%	-98.09%	-41.22%
NET CHANGE
Cash From Operating Activities	48.70M	$56.06M	31.30M
Cash From Investing Activities	-6.700M	-$47.91M	-5.800M
Cash From Financing Activities	-17.10M	-$4.138M	-15.40M
Net Change In Cash	24.90M	$7.285M	10.10M
YoY Change	146.53%	-95.85%	-163.92%
FREE CASH FLOW
Cash From Operating Activities	$48.70M	$56.06M	$31.30M
Capital Expenditures	-$6.700M	$43.68M	-$5.600M
Free Cash Flow	$55.40M	$12.38M	$36.90M
YoY Change	50.14%	-96.9%	-15.75%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2017	dei	Amendment Flag AmendmentFlag	false
CY2017	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-30
CY2017	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2017	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2017
CY2017	dei	Document Period End Date DocumentPeriodEndDate	2017-12-30
CY2017	dei	Trading Symbol TradingSymbol	MASI
CY2016Q4	masi	Accrued Stock Repurchase Current AccruedStockRepurchaseCurrent	0	USD
CY2017Q4	masi	Accrued Stock Repurchase Current AccruedStockRepurchaseCurrent	1988000	USD
CY2016Q4	masi	Accruedcustomerrebatesfeesandreimbursement Accruedcustomerrebatesfeesandreimbursement	10673000	USD
CY2017Q4	masi	Accruedcustomerrebatesfeesandreimbursement Accruedcustomerrebatesfeesandreimbursement	16896000	USD
CY2016	masi	Effective Income Tax Rate Reconciliation Impactof2017 Tax Act EffectiveIncomeTaxRateReconciliationImpactof2017TaxAct	0
CY2017	dei	Entity Registrant Name EntityRegistrantName	MASIMO CORP
CY2017	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2017	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2017	dei	Document Type DocumentType	10-K
CY2017	dei	Entity Central Index Key EntityCentralIndexKey	0000937556
CY2017Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	51636352	shares
CY2017	dei	Entity Current Reporting Status EntityCurrentReportingStatus	No
CY2017	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2017Q3	dei	Entity Public Float EntityPublicFloat	3844000000	USD
CY2016Q4	masi	Amount Of Unrecognized Benefits Affecting Future Tax Rate AmountOfUnrecognizedBenefitsAffectingFutureTaxRate	13100000	USD
CY2017Q4	masi	Amount Of Unrecognized Benefits Affecting Future Tax Rate AmountOfUnrecognizedBenefitsAffectingFutureTaxRate	14500000	USD
CY2017Q4	masi	Bank Balances BankBalances	315200000	USD
CY2016Q4	masi	Concentration Risk Customer Accounts Receivable Percentage ConcentrationRiskCustomerAccountsReceivablePercentage	0.136
CY2016Q1	masi	Concentration Risk Longlived Asset Geographic Area Percentage ConcentrationRiskLonglivedAssetGeographicAreaPercentage	1.000
CY2016Q4	masi	Concentration Risk Longlived Asset Geographic Area Percentage ConcentrationRiskLonglivedAssetGeographicAreaPercentage	1.000
CY2017Q4	masi	Concentration Risk Longlived Asset Geographic Area Percentage ConcentrationRiskLonglivedAssetGeographicAreaPercentage	1.000
CY2016Q4	masi	Deferred Cost Of Goods Sold DeferredCostOfGoodsSold	79948000	USD
CY2017Q4	masi	Deferred Cost Of Goods Sold DeferredCostOfGoodsSold	99600000	USD
CY2016	masi	Earnings Per Share Diluted Effectof Foreign Tax Benefit Relatingto Businessand Employment Actions EarningsPerShareDilutedEffectofForeignTaxBenefitRelatingtoBusinessandEmploymentActions	0.02
CY2016	masi	Earnings Per Share Diluted Effectof Foreign Tax Benefit Relatingto Businessand Employment Actions EarningsPerShareDilutedEffectofForeignTaxBenefitRelatingtoBusinessandEmploymentActions	0.09
CY2017	masi	Earnings Per Share Diluted Effectof Foreign Tax Benefit Relatingto Businessand Employment Actions EarningsPerShareDilutedEffectofForeignTaxBenefitRelatingtoBusinessandEmploymentActions	0.02
CY2016	masi	Effective Income Tax Rate Reconciliation Impactof2017 Tax Act EffectiveIncomeTaxRateReconciliationImpactof2017TaxAct	0
CY2017	masi	Effective Income Tax Rate Reconciliation Impactof2017 Tax Act EffectiveIncomeTaxRateReconciliationImpactof2017TaxAct	0.185
CY2017Q4	masi	Estimateof Annual Preventable Hospital Deaths Preventedby2020 EstimateofAnnualPreventableHospitalDeathsPreventedby2020	200000	death
CY2016Q4	masi	Finite Lived Patents Gross Not Amortized FiniteLivedPatentsGrossNotAmortized	5000000	USD
CY2017Q4	masi	Finite Lived Patents Gross Not Amortized FiniteLivedPatentsGrossNotAmortized	4300000	USD
CY2016Q4	masi	Finite Lived Trademarks Gross Not Amortized FiniteLivedTrademarksGrossNotAmortized	600000	USD
CY2017Q4	masi	Finite Lived Trademarks Gross Not Amortized FiniteLivedTrademarksGrossNotAmortized	600000	USD
CY2016	masi	Foreign Tax Expense Benefit Businessand Employment Actions ForeignTaxExpenseBenefitBusinessandEmploymentActions	-1300000	USD
CY2016	masi	Foreign Tax Expense Benefit Businessand Employment Actions ForeignTaxExpenseBenefitBusinessandEmploymentActions	-4600000	USD
CY2017	masi	Foreign Tax Expense Benefit Businessand Employment Actions ForeignTaxExpenseBenefitBusinessandEmploymentActions	-1000000	USD
CY2016Q4	masi	Income Tax Payable Noncurrent IncomeTaxPayableNoncurrent	0	USD
CY2017Q4	masi	Income Tax Payable Noncurrent IncomeTaxPayableNoncurrent	25734000	USD
CY2017	masi	Indefinitely Carryforward Research And Development Credits IndefinitelyCarryforwardResearchAndDevelopmentCredits	6300000	USD
CY2016Q4	masi	Inventory Finished Goods Held By Distributors InventoryFinishedGoodsHeldByDistributors	4900000	USD
CY2017Q4	masi	Inventory Finished Goods Held By Distributors InventoryFinishedGoodsHeldByDistributors	3700000	USD
CY2007Q1	masi	Numberof Companieswith Rightsto Intellectual Property NumberofCompanieswithRightstoIntellectualProperty	2	company
CY2014Q1	masi	Numberof Participantsinthe Surfactant Positive Pressureand Oxygenation Randomized Trial NumberofParticipantsintheSurfactantPositivePressureandOxygenationRandomizedTrial	2	participant
CY2017	masi	Numberof Sourcesof Product Revenue NumberofSourcesofProductRevenue	4	segment
CY2017Q4	masi	Operating Loss Carryforwards Gross OperatingLossCarryforwardsGross	3600000	USD
CY2015Q3	masi	Patentand Licensing Fee Aggregate PatentandLicensingFeeAggregate	2400000	USD
CY2016	masi	Percentage Of Product Revenue Based On Geographic Area By Destination PercentageOfProductRevenueBasedOnGeographicAreaByDestination	1
CY2016	masi	Percentage Of Product Revenue Based On Geographic Area By Destination PercentageOfProductRevenueBasedOnGeographicAreaByDestination	1
CY2017	masi	Percentage Of Product Revenue Based On Geographic Area By Destination PercentageOfProductRevenueBasedOnGeographicAreaByDestination	1
CY2016	masi	Percentage Of Shares Outstanding PercentageOfSharesOutstanding	0.03
CY2016	masi	Proceedsfromstockoptionsexercisedunsettledatperiodend Proceedsfromstockoptionsexercisedunsettledatperiodend	0	USD
CY2016	masi	Proceedsfromstockoptionsexercisedunsettledatperiodend Proceedsfromstockoptionsexercisedunsettledatperiodend	165000	USD
CY2017	masi	Proceedsfromstockoptionsexercisedunsettledatperiodend Proceedsfromstockoptionsexercisedunsettledatperiodend	161000	USD
CY2017	masi	Product Life Estimate ProductLifeEstimate	P7Y
CY2016	masi	Product Revenue ProductRevenue	599334000	USD
CY2016	masi	Product Revenue ProductRevenue	663846000	USD
CY2017	masi	Product Revenue ProductRevenue	741324000	USD
CY2016Q1	masi	Property Plantand Equipment Occupied Square Feet PropertyPlantandEquipmentOccupiedSquareFeet	70700	sqft
CY2016Q3	masi	Property Plantand Equipment Occupied Square Feet PropertyPlantandEquipmentOccupiedSquareFeet	32518	sqft
CY2017	masi	Property Plantand Equipment Occupied Square Feet PropertyPlantandEquipmentOccupiedSquareFeet	16830	sqft
CY2016	masi	Provisionforamountduefromforeignagent Provisionforamountduefromforeignagent	0	USD
CY2016	masi	Provisionforamountduefromforeignagent Provisionforamountduefromforeignagent	0	USD
CY2017	masi	Provisionforamountduefromforeignagent Provisionforamountduefromforeignagent	10477000	USD
CY2017	masi	Royalty Royalty	32800000	USD
CY2017	masi	Royalty Rate Percentage RoyaltyRatePercentage	0.0775
CY2016Q4	masi	Royalty Receivable RoyaltyReceivable	7500000	USD
CY2017Q4	masi	Royalty Receivable RoyaltyReceivable	7400000	USD
CY2017	masi	Royalty Revenue Numberof Days Royalty Revenueis Adjusted Subsequentto Quarter End RoyaltyRevenueNumberofDaysRoyaltyRevenueisAdjustedSubsequenttoQuarterEnd	P60D
CY2016	masi	Royaltyand Other Revenue RoyaltyandOtherRevenue	30777000	USD
CY2016	masi	Royaltyand Other Revenue RoyaltyandOtherRevenue	30779000	USD
CY2017	masi	Royaltyand Other Revenue RoyaltyandOtherRevenue	56784000	USD
CY2017Q4	masi	Severance Plan Participation Agreements SeverancePlanParticipationAgreements	5	Agreement
CY2016	masi	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term Price Below Market Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermPriceBelowMarketValue	P5Y7M6D
CY2017	masi	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term Price Below Market Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermPriceBelowMarketValue	P5Y10M24D
CY2016	masi	Statutory Regular Federal Income Tax Rate StatutoryRegularFederalIncomeTaxRate	0.35
CY2016	masi	Statutory Regular Federal Income Tax Rate StatutoryRegularFederalIncomeTaxRate	0.35
CY2017	masi	Statutory Regular Federal Income Tax Rate StatutoryRegularFederalIncomeTaxRate	0.35
CY2016	masi	Stockrepurchasedunsettledatperiodend Stockrepurchasedunsettledatperiodend	4815000	USD
CY2016	masi	Stockrepurchasedunsettledatperiodend Stockrepurchasedunsettledatperiodend	0	USD
CY2017	masi	Stockrepurchasedunsettledatperiodend Stockrepurchasedunsettledatperiodend	1988000	USD
CY2017	masi	Supplemental Unemployment Benefits Severance Benefits Required Noticeof Resignation SupplementalUnemploymentBenefitsSeveranceBenefitsRequiredNoticeofResignation	P6M
CY2016	masi	Tax And Accrued Interest Related To Uncertain Tax Positions Increase Decrease TaxAndAccruedInterestRelatedToUncertainTaxPositionsIncreaseDecrease	600000	USD
CY2016	masi	Tax And Accrued Interest Related To Uncertain Tax Positions Increase Decrease TaxAndAccruedInterestRelatedToUncertainTaxPositionsIncreaseDecrease	6100000	USD
CY2017	masi	Tax And Accrued Interest Related To Uncertain Tax Positions Increase Decrease TaxAndAccruedInterestRelatedToUncertainTaxPositionsIncreaseDecrease	1600000	USD
CY2017	masi	Tax Cutsand Jobs Act Changein Tax Rate Income Tax Expense Benefit TaxCutsandJobsActChangeinTaxRateIncomeTaxExpenseBenefit	9000000	USD
CY2017Q4	masi	Tax Cutsand Jobs Act Deferred Tax Liability Not Recognized Amountof Unrecognized Deferred Tax Liability Undistributed Earningsof Foreign Subsidiary TaxCutsandJobsActDeferredTaxLiabilityNotRecognizedAmountofUnrecognizedDeferredTaxLiabilityUndistributedEarningsofForeignSubsidiary	1900000	USD
CY2017	masi	Tax Cutsand Jobs Act Income Tax Expense Benefit TaxCutsandJobsActIncomeTaxExpenseBenefit	43500000	USD
CY2017	masi	Tax Cutsand Jobs Act Transition Tax Accumulated Undistributed Foreign Earnings Subjectto Transition Tax TaxCutsandJobsActTransitionTaxAccumulatedUndistributedForeignEarningsSubjecttoTransitionTax	217400000	USD
CY2017	masi	Tax Cutsand Jobs Act Transition Tax Foreign Withholding Tax TaxCutsandJobsActTransitionTaxForeignWithholdingTax	6500000	USD
CY2017	masi	Tax Cutsand Jobs Act Transition Taxfor Accumulated Foreign Earnings Provisional Income Tax Expense TaxCutsandJobsActTransitionTaxforAccumulatedForeignEarningsProvisionalIncomeTaxExpense	28000000	USD
CY2017	masi	Tax Cutsand Jobs Act Undistributed Accumulated Earningson Foreign Subsidiary TaxCutsandJobsActUndistributedAccumulatedEarningsonForeignSubsidiary	180000000	USD
CY2016Q4	masi	Unamortized Cost By Company UnamortizedCostByCompany	700000	USD
CY2016Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	76316000	USD
CY2016Q4	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	3893000	USD
CY2017Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	4292000	USD
CY2017Q4	masi	Unamortized Cost By Company UnamortizedCostByCompany	800000	USD
CY2016Q4	masi	Unrecognized Tax Benefits Liabilities Noncurrent UnrecognizedTaxBenefitsLiabilitiesNoncurrent	13442000	USD
CY2017Q4	masi	Unrecognized Tax Benefits Liabilities Noncurrent UnrecognizedTaxBenefitsLiabilitiesNoncurrent	14348000	USD
CY2016Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	34335000	USD
CY2017Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	33779000	USD
CY2017Q4	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	3683000	USD
CY2016Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	101667000	USD
CY2017Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	121309000	USD
CY2016Q4	us-gaap	Accounts Receivable Related Parties Current AccountsReceivableRelatedPartiesCurrent	77000	USD
CY2017Q4	us-gaap	Accounts Receivable Related Parties Current AccountsReceivableRelatedPartiesCurrent	39000	USD
CY2016Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	28266000	USD
CY2017Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	38052000	USD
CY2016Q4	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	1362000	USD
CY2017Q4	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	975000	USD
CY2016Q4	us-gaap	Accrued Rent Current And Noncurrent AccruedRentCurrentAndNoncurrent	700000	USD
CY2017Q4	us-gaap	Accrued Rent Current And Noncurrent AccruedRentCurrentAndNoncurrent	1500000	USD
CY2016Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	68233000	USD
CY2017Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	82237000	USD
CY2016Q4	us-gaap	Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax	-7027000	USD
CY2017Q4	us-gaap	Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax	-2941000	USD
CY2016Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	382263000	USD
CY2017Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	461494000	USD
CY2016	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	472000	USD
CY2016	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	10825000	USD
CY2016	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	12503000	USD
CY2017	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	17187000	USD
CY2016	us-gaap	Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation	5058000	USD
CY2016	us-gaap	Advertising Expense AdvertisingExpense	10700000	USD
CY2016	us-gaap	Advertising Expense AdvertisingExpense	11000000	USD
CY2017	us-gaap	Advertising Expense AdvertisingExpense	12800000	USD
CY2016	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	10825000	USD
CY2016Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1698000	USD
CY2016Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	2116000	USD
CY2016	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	700000	shares
CY2016	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	200000	shares
CY2017	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	400000	shares
CY2016Q4	us-gaap	Assets Assets	820525000	USD
CY2017Q4	us-gaap	Assets Assets	910235000	USD
CY2016Q4	us-gaap	Assets Current AssetsCurrent	507227000	USD
CY2017Q4	us-gaap	Assets Current AssetsCurrent	564119000	USD
CY2016	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	4371000	USD
CY2015Q1	us-gaap	Capitalized Software Development Costs For Software Sold To Customers CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers	500000	USD
CY2015Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	134604000	USD
CY2016	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	2009000	USD
CY2017	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1559000	USD
CY2016Q4	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	71000	USD
CY2017Q4	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	0	USD
CY2016	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	200000	USD
CY2016	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	100000	USD
CY2017	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	1900000	USD
CY2016Q1	us-gaap	Capitalized Software Development Costs For Software Sold To Customers CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers	500000	USD
CY2016Q4	us-gaap	Capitalized Software Development Costs For Software Sold To Customers CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers	0	USD
CY2016Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	132317000	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	305970000	USD
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	315302000	USD
CY2016Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	132462000	USD
CY2016Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	308198000	USD
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	315483000	USD
CY2016	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2142000	USD
CY2016	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	175736000	USD
CY2017	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	7285000	USD
CY2017Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	3300000	USD
CY2016Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2017Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2017Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	13800000	shares
CY2016Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2016Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2016Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2016Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2016Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	50188000	shares
CY2016Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	51636000	shares
CY2016Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	50000	USD
CY2017Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	52000	USD
CY2016	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	80654000	USD
CY2016	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	298378000	USD
CY2017	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	135702000	USD
CY2016Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	7923000	USD
CY2016	us-gaap	Cost Of Goods Sold CostOfGoodsSold	220128000	USD
CY2016	us-gaap	Cost Of Goods Sold CostOfGoodsSold	230826000	USD
CY2017	us-gaap	Cost Of Goods Sold CostOfGoodsSold	263008000	USD
CY2016	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	31983000	USD
CY2016	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	99533000	USD
CY2017	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	38777000	USD
CY2016	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	2448000	USD
CY2016	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	5815000	USD
CY2017	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	3018000	USD
CY2016	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	36819000	USD
CY2016	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	112270000	USD
CY2017	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	43735000	USD
CY2016	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	2388000	USD
CY2016	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	6922000	USD
CY2017	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	1940000	USD
CY2016Q4	us-gaap	Customer Advances Or Deposits Noncurrent CustomerAdvancesOrDepositsNoncurrent	5933000	USD
CY2017Q4	us-gaap	Customer Advances Or Deposits Noncurrent CustomerAdvancesOrDepositsNoncurrent	6114000	USD
CY2016	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount	0	USD
CY2016	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount	273000	USD
CY2017	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount	0	USD
CY2016Q2	us-gaap	Deconsolidation Revaluation Of Retained Investment Gain Or Loss Amount DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount	300000	USD
CY2016Q4	us-gaap	Deferred Credits And Other Liabilities DeferredCreditsAndOtherLiabilities	247000	USD
CY2017Q4	us-gaap	Deferred Credits And Other Liabilities DeferredCreditsAndOtherLiabilities	292000	USD
CY2016	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-900000	USD
CY2016	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	2982000	USD
CY2017	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	27002000	USD
CY2016	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	132000	USD
CY2016	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	92000	USD
CY2017	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	22000	USD
CY2016	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-1974000	USD
CY2016	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	5405000	USD
CY2017	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	24023000	USD
CY2016Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	558000	USD
CY2017Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	1266000	USD
CY2016Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	38198000	USD
CY2017Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	35929000	USD
CY2016Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	25336000	USD
CY2017Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	237000	USD
CY2016	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-1206000	USD
CY2016	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	2331000	USD
CY2017	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-3001000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	5393000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	3831000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	43021000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	28497000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	38635000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	14019000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	43021000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	28497000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	38975000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	23898000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	802000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	6414000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	18680000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	8601000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Other DeferredTaxAssetsTaxDeferredExpenseOther	1902000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Other DeferredTaxAssetsTaxDeferredExpenseOther	237000	USD
CY2017Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	9880000	USD
CY2016	us-gaap	Depreciation Depreciation	13000000	USD
CY2017	us-gaap	Depreciation Depreciation	15200000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	16244000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	9414000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	0	USD
CY2017Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	0	USD
CY2016Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	4386000	USD
CY2017Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	14478000	USD
CY2016Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	340000	USD
CY2016Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	1695000	USD
CY2017Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	1990000	USD
CY2016Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	2691000	USD
CY2017Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	2988000	USD
CY2016Q4	us-gaap	Deferred Tax Liability Not Recognized Amount Of Unrecognized Deferred Tax Liability Undistributed Earnings Of Foreign Subsidiaries DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityUndistributedEarningsOfForeignSubsidiaries	0	USD
CY2017Q4	us-gaap	Deferred Tax Liability Not Recognized Amount Of Unrecognized Deferred Tax Liability Undistributed Earnings Of Foreign Subsidiaries DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityUndistributedEarningsOfForeignSubsidiaries	9500000	USD
CY2017	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Percent DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent	0.03
CY2016Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	2943000	USD
CY2017Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	3286000	USD
CY2016	us-gaap	Depreciation Depreciation	11800000	USD
CY2016	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	15684000	USD
CY2016	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	16817000	USD
CY2017	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	20061000	USD
CY2016Q4	us-gaap	Due From Employees Current DueFromEmployeesCurrent	305000	USD
CY2017Q4	us-gaap	Due From Employees Current DueFromEmployeesCurrent	364000	USD
CY2016Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	525000	USD
CY2017Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	1529000	USD
CY2016	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.62
CY2016Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.56
CY2016Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.61
CY2016Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.56
CY2016Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	4.31
CY2016	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	6.07
CY2017Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.90
CY2017Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.90
CY2017Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.75
CY2017Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.01
CY2017	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.55
CY2016	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.55
CY2016Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.53
CY2016Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.57
CY2016Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.52
CY2016Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	3.97
CY2016	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	5.65
CY2017Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.82
CY2017Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.83
CY2017Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	3817000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	4958000	USD
CY2017Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.70
CY2017Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.01
CY2017	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.36
CY2016	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-2681000	USD
CY2016	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-1451000	USD
CY2017	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3269000	USD
CY2016	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.300
CY2016	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.281
CY2017	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.340
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.004
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.000
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.063
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.056
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.034
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0.017
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0.008
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0.018
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.000
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.030
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.189
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	-0.002
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	0.000
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	0.000
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Repatriation Of Foreign Earnings EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings	0.000
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Repatriation Of Foreign Earnings EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings	0.000
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Repatriation Of Foreign Earnings EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings	0.033
CY2016	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.007
CY2016	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.014
CY2017	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.003
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	0.017
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	0.005
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	0.020
CY2016Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	43180000	USD
CY2017Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	39515000	USD
CY2016	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	3700000	USD
CY2016	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	16200000	USD
CY2017	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	39200000	USD
CY2016Q4	us-gaap	Equity Method Investments EquityMethodInvestments	200000	USD
CY2017Q4	us-gaap	Equity Method Investments EquityMethodInvestments	1234000	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	21313000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	24675000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	7725000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	5420000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	1768000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	3435000	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	50689000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	51798000	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	29376000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	27123000	USD
CY2016	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	500000	USD
CY2016	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	100000	USD
CY2017	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	300000	USD
CY2016	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-608000	USD
CY2016	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-658000	USD
CY2017	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-522000	USD
CY2016Q1	us-gaap	Goodwill Goodwill	20394000	USD
CY2016Q4	us-gaap	Goodwill Goodwill	19780000	USD
CY2017Q4	us-gaap	Goodwill Goodwill	20617000	USD
CY2016	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	0	USD
CY2016	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	0	USD
CY2017	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	400000.0	USD
CY2016	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-614000	USD
CY2017	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	837000	USD
CY2016	us-gaap	Gross Profit GrossProfit	409983000	USD
CY2016Q2	us-gaap	Gross Profit GrossProfit	114213000	USD
CY2016Q3	us-gaap	Gross Profit GrossProfit	115135000	USD
CY2016Q4	us-gaap	Gross Profit GrossProfit	110122000	USD
CY2016Q4	us-gaap	Gross Profit GrossProfit	124329000	USD
CY2016	us-gaap	Gross Profit GrossProfit	463799000	USD
CY2017Q2	us-gaap	Gross Profit GrossProfit	124134000	USD
CY2017Q3	us-gaap	Gross Profit GrossProfit	128437000	USD
CY2017Q3	us-gaap	Gross Profit GrossProfit	128665000	USD
CY2017Q4	us-gaap	Gross Profit GrossProfit	153864000	USD
CY2017	us-gaap	Gross Profit GrossProfit	535100000	USD
CY2016	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	87762000	USD
CY2016	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	320702000	USD
CY2017	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	171564000	USD
CY2016	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	28583000	USD
CY2016	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	97639000	USD
CY2017	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	27810000	USD
CY2016	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	116345000	USD
CY2016	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	418341000	USD
CY2017	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	199374000	USD
CY2016	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	34845000	USD
CY2016	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	117675000	USD
CY2017	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	67758000	USD
CY2016	us-gaap	Income Taxes Paid IncomeTaxesPaid	36194000	USD
CY2016	us-gaap	Income Taxes Paid IncomeTaxesPaid	31230000	USD
CY2017	us-gaap	Income Taxes Paid IncomeTaxesPaid	91061000	USD
CY2016	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-3619000	USD
CY2016	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	11048000	USD
CY2017	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-4057000	USD
CY2016	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	9900000	USD
CY2016	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	21243000	USD
CY2017	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	19772000	USD
CY2016	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	1316000	USD
CY2016	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	73755000	USD
CY2017	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-72087000	USD
CY2016	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	19202000	USD
CY2016	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-11929000	USD
CY2017	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	11156000	USD
CY2016	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	78000	USD
CY2016	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	8251000	USD
CY2017	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	19438000	USD
CY2016	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	58000	USD
CY2016	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	41977000	USD
CY2017	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-27370000	USD
CY2016	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	5334000	USD
CY2016	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	5675000	USD
CY2017	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-4292000	USD
CY2016	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-7505000	USD
CY2016	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	10831000	USD
CY2017	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	22923000	USD
CY2016	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	2883000	USD
CY2016	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	1609000	USD
CY2017	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	10952000	USD
CY2016	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-4587000	USD
CY2016	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	6565000	USD
CY2017	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	28013000	USD
CY2016	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	135000	USD
CY2016	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	3422000	USD
CY2017	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	3855000	USD
CY2016	us-gaap	Increase Decrease In Prepaid Taxes IncreaseDecreaseInPrepaidTaxes	1992000	USD
CY2016	us-gaap	Increase Decrease In Prepaid Taxes IncreaseDecreaseInPrepaidTaxes	-1355000	USD
CY2017	us-gaap	Increase Decrease In Prepaid Taxes IncreaseDecreaseInPrepaidTaxes	2498000	USD
CY2016	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	2396000	shares
CY2016	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	3665000	shares
CY2017	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	4358000	shares
CY2016Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	29376000	USD
CY2017Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	27123000	USD
CY2016	us-gaap	Interest Paid Net InterestPaidNet	2293000	USD
CY2016	us-gaap	Interest Paid Net InterestPaidNet	4052000	USD
CY2017	us-gaap	Interest Paid Net InterestPaidNet	551000	USD
CY2016Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	32194000	USD
CY2017Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	56125000	USD
CY2016Q4	us-gaap	Inventory Net InventoryNet	72542000	USD
CY2017	us-gaap	Investment Tax Credit InvestmentTaxCredit	400000	USD
CY2016	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	5200000	USD
CY2017Q4	us-gaap	Inventory Net InventoryNet	95944000	USD
CY2016Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	32647000	USD
CY2017Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	31200000	USD
CY2016Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	7701000	USD
CY2017Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	8619000	USD
CY2016	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	5300000	USD
CY2017	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	6700000	USD
CY2016Q1	us-gaap	Lessee Leasing Arrangements Operating Leases Term Of Contract LesseeLeasingArrangementsOperatingLeasesTermOfContract	P10Y
CY2016Q3	us-gaap	Lessee Leasing Arrangements Operating Leases Term Of Contract LesseeLeasingArrangementsOperatingLeasesTermOfContract	P10Y
CY2016Q4	us-gaap	Liabilities Liabilities	260289000	USD
CY2017Q4	us-gaap	Liabilities Liabilities	203324000	USD
CY2016Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	820525000	USD
CY2017Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	910235000	USD
CY2016Q4	us-gaap	Liabilities Current LiabilitiesCurrent	220366000	USD
CY2017Q4	us-gaap	Liabilities Current LiabilitiesCurrent	151567000	USD
CY2016	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	-19609000	USD
CY2016	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	-270000000	USD
CY2017	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	0	USD
CY2017Q4	us-gaap	Loss Contingency Estimate Of Possible Loss LossContingencyEstimateOfPossibleLoss	10500000	USD
CY2016	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-62073000	USD
CY2016	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-216624000	USD
CY2017	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-4138000	USD
CY2016	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-54594000	USD
CY2016	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-25314000	USD
CY2017	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-47908000	USD
CY2016	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	117206000	USD
CY2016	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	419125000	USD
CY2017	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	56062000	USD
CY2016	us-gaap	Net Income Loss NetIncomeLoss	83300000	USD
CY2016Q2	us-gaap	Net Income Loss NetIncomeLoss	27577000	USD
CY2016Q3	us-gaap	Net Income Loss NetIncomeLoss	30023000	USD
CY2016Q4	us-gaap	Net Income Loss NetIncomeLoss	27773000	USD
CY2016Q4	us-gaap	Net Income Loss NetIncomeLoss	215293000	USD
CY2016	us-gaap	Net Income Loss NetIncomeLoss	300666000	USD
CY2017Q2	us-gaap	Net Income Loss NetIncomeLoss	45334000	USD
CY2017Q3	us-gaap	Net Income Loss NetIncomeLoss	46680000	USD
CY2017Q3	us-gaap	Net Income Loss NetIncomeLoss	39235000	USD
CY2017Q4	us-gaap	Net Income Loss NetIncomeLoss	367000	USD
CY2017	us-gaap	Net Income Loss NetIncomeLoss	131616000	USD
CY2016	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1800000	USD
CY2016	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	USD
CY2017	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	USD
CY2016	us-gaap	Noncontrolling Interest Decrease From Deconsolidation NoncontrollingInterestDecreaseFromDeconsolidation	297000	USD
CY2016	us-gaap	Noncontrolling Interest Increase From Subsidiary Equity Issuance NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance	347000	USD
CY2016Q1	us-gaap	Noncurrent Assets NoncurrentAssets	210323000	USD
CY2016Q4	us-gaap	Noncurrent Assets NoncurrentAssets	225167000	USD
CY2017Q4	us-gaap	Noncurrent Assets NoncurrentAssets	274478000	USD
CY2016	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-3905000	USD
CY2016	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2429000	USD
CY2017	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	2013000	USD
CY2017	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2016	us-gaap	Operating Expenses OperatingExpenses	289733000	USD
CY2016	us-gaap	Operating Expenses OperatingExpenses	43029000	USD
CY2017	us-gaap	Operating Expenses OperatingExpenses	337739000	USD
CY2016	us-gaap	Operating Income Loss OperatingIncomeLoss	120250000	USD
CY2016Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	37337000	USD
CY2016Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	36429000	USD
CY2016Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	36604000	USD
CY2016Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	310400000	USD
CY2016	us-gaap	Operating Income Loss OperatingIncomeLoss	420770000	USD
CY2017Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	43195000	USD
CY2017Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	46868000	USD
CY2017Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	47975000	USD
CY2017Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	59323000	USD
CY2017	us-gaap	Operating Income Loss OperatingIncomeLoss	197361000	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	25305000	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	6748000	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	1816000	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	2597000	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	3184000	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	5493000	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	5467000	USD
CY2016Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	5768000	USD
CY2017Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	5121000	USD
CY2016Q4	us-gaap	Other Assets Current OtherAssetsCurrent	26067000	USD
CY2017Q4	us-gaap	Other Assets Current OtherAssetsCurrent	28070000	USD
CY2016Q4	us-gaap	Other Assets Miscellaneous Current OtherAssetsMiscellaneousCurrent	3053000	USD
CY2017Q4	us-gaap	Other Assets Miscellaneous Current OtherAssetsMiscellaneousCurrent	3161000	USD
CY2016Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	9223000	USD
CY2017Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	10782000	USD
CY2016	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax	-2646000	USD
CY2016	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax	-2288000	USD
CY2017	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax	4201000	USD
CY2016	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-2646000	USD
CY2016	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-2288000	USD
CY2017	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	4201000	USD
CY2016	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	78854000	USD
CY2016	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	298378000	USD
CY2017	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	135702000	USD
CY2016	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	0	USD
CY2016	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	0	USD
CY2017	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-115000	USD
CY2017	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	-115000	USD
CY2016Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	14587000	USD
CY2017Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	51520000	USD
CY2016	us-gaap	Payments For Proceeds From Longterm Investments PaymentsForProceedsFromLongtermInvestments	0	USD
CY2016	us-gaap	Payments For Proceeds From Longterm Investments PaymentsForProceedsFromLongtermInvestments	200000	USD
CY2016	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	621000	USD
CY2017	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	USD
CY2016Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2017	us-gaap	Payments For Proceeds From Longterm Investments PaymentsForProceedsFromLongtermInvestments	1145000	USD
CY2016	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	150152000	USD
CY2016	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	68218000	USD
CY2017	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	66272000	USD
CY2016	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	USD
CY2016	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	472000	USD
CY2016	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	0	USD
CY2017	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	0	USD
CY2016	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
CY2016	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	763000	USD
CY2017	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
CY2016	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	4201000	USD
CY2016	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	4644000	USD
CY2017	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	3079000	USD
CY2016	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	50393000	USD
CY2016	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	19707000	USD
CY2017	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	43684000	USD
CY2016Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2016Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2016Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2016Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2016Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2016Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2016Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2016Q4	us-gaap	Preferred Stock Value Outstanding PreferredStockValueOutstanding	0	USD
CY2017Q4	us-gaap	Preferred Stock Value Outstanding PreferredStockValueOutstanding	0	USD
CY2016Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	13051000	USD
CY2017Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	17073000	USD
CY2016Q4	us-gaap	Prepaid Taxes PrepaidTaxes	981000	USD
CY2017Q4	us-gaap	Prepaid Taxes PrepaidTaxes	3494000	USD
CY2016	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	130000000	USD
CY2016	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	45000000	USD
CY2017	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	0	USD
CY2016	us-gaap	Proceeds From Payments To Minority Shareholders ProceedsFromPaymentsToMinorityShareholders	346000	USD
CY2016	us-gaap	Proceeds From Payments To Minority Shareholders ProceedsFromPaymentsToMinorityShareholders	0	USD
CY2017	us-gaap	Proceeds From Payments To Minority Shareholders ProceedsFromPaymentsToMinorityShareholders	0	USD
CY2016	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	28285000	USD
CY2016	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	37290000	USD
CY2017	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	62205000	USD
CY2015Q1	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	1416000	USD
CY2016Q1	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	1222000	USD
CY2016Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	910000	USD
CY2017Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	1149000	USD
CY2017Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	246333000	USD
CY2016Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	135996000	USD
CY2016Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	910000	USD
CY2017Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	1149000	USD
CY2016	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	1055000	USD
CY2016	us-gaap	Product Warranty Expense ProductWarrantyExpense	61000	USD
CY2016	us-gaap	Product Warranty Expense ProductWarrantyExpense	110000	USD
CY2017	us-gaap	Product Warranty Expense ProductWarrantyExpense	332000	USD
CY2016	us-gaap	Profit Loss ProfitLoss	81500000	USD
CY2016	us-gaap	Profit Loss ProfitLoss	300666000	USD
CY2017	us-gaap	Profit Loss ProfitLoss	131616000	USD
CY2016Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	204229000	USD
CY2016	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	1293000	USD
CY2017	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	1154000	USD
CY2016	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	800000	USD
CY2016	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	871000	USD
CY2017	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	1061000	USD
CY2017Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	164096000	USD
CY2016	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	342000	USD
CY2016	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	259000	USD
CY2017	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	251000	USD
CY2017Q4	us-gaap	Purchase Commitment Remaining Minimum Amount Committed PurchaseCommitmentRemainingMinimumAmountCommitted	74100000	USD
CY2016	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	70000000	USD
CY2016	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	230000000	USD
CY2017	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	0	USD
CY2016	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	80000	USD
CY2016	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	75000	USD
CY2017	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	71000	USD
CY2016	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	56617000	USD
CY2016	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	59362000	USD
CY2017	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	61953000	USD
CY2016Q1	us-gaap	Restricted Cash RestrictedCash	145000	USD
CY2016Q4	us-gaap	Restricted Cash RestrictedCash	2228000	USD
CY2017Q4	us-gaap	Restricted Cash RestrictedCash	181000	USD
CY2016Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	2081000	USD
CY2017Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	33000	USD
CY2016Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	147000	USD
CY2017Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	148000	USD
CY2016Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	589226000	USD
CY2017Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	720842000	USD
CY2016	us-gaap	Revenues Revenues	630111000	USD
CY2016Q2	us-gaap	Revenues Revenues	171167000	USD
CY2016Q3	us-gaap	Revenues Revenues	172636000	USD
CY2016Q4	us-gaap	Revenues Revenues	167621000	USD
CY2016Q4	us-gaap	Revenues Revenues	183201000	USD
CY2016	us-gaap	Revenues Revenues	694625000	USD
CY2017Q2	us-gaap	Revenues Revenues	186302000	USD
CY2017Q3	us-gaap	Revenues Revenues	192933000	USD
CY2017Q3	us-gaap	Revenues Revenues	193692000	USD
CY2017Q4	us-gaap	Revenues Revenues	225181000	USD
CY2017	us-gaap	Revenues Revenues	798108000	USD
CY2016	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	252725000	USD
CY2016	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	253667000	USD
CY2017	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	275786000	USD
CY2016	us-gaap	Share Based Compensation ShareBasedCompensation	10825000	USD
CY2016	us-gaap	Share Based Compensation ShareBasedCompensation	12503000	USD
CY2017	us-gaap	Share Based Compensation ShareBasedCompensation	17187000	USD
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.00
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.00
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.00
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.365
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.374
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.374
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.317
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.320
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.320
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.019
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.019
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.019
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.014
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.013
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.013
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	3900000	shares
CY2016Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	5609000	shares
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	4988000	shares
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	3812000	shares
CY2016Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	24.72
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	26.33
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	26.28
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	26400000	USD
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	57000000	USD
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	140300000	USD
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	0	shares
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	0	shares
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	0	shares
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	218000	shares
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	172000	shares
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	250000	shares
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	914000	shares
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	1290000	shares
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	928000	shares
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	12.20
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	13.64
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	27.81
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	339700000	USD
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	9956000	shares
CY2016Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	9202000	shares
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	8521000	shares
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	6953000	shares
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	23.59
CY2016Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	25.46
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	28.56
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	36.26
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	223100000	USD
CY2016	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	19.54
CY2016	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	20.76
CY2017	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	27.63
CY2016	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	0
CY2016	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	0
CY2017	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	0
CY2016	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	24.33
CY2016	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	29.13
CY2017	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	38.59
CY2016	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	36.18
CY2016	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	39.94
CY2017	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	86.69
CY2016	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P3Y10M24D
CY2017	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P4Y3M18D
CY2016	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y6M26D
CY2017	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y11M1D
CY2016	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	10400000	USD
CY2016	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	10600000	USD
CY2017	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	27800000	USD
CY2016	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	4000	shares
CY2017	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	6000	shares
CY2016	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	1450000	shares
CY2016	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	1799000	shares
CY2017	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	2246000	shares
CY2016	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	28326000	USD
CY2016	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	37342000	USD
CY2017	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	62046000	USD
CY2015Q3	us-gaap	Stock Repurchase Program Number Of Shares Authorized To Be Repurchased StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased	5000000.0	shares
CY2017Q4	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	2100000	USD
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	560236000	USD
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	706911000	USD
CY2015Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	307741000	USD
CY2016Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	275712000	USD
CY2016Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	560236000	USD
CY2017Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	706911000	USD
CY2016	us-gaap	Tax Adjustments Settlements And Unusual Provisions TaxAdjustmentsSettlementsAndUnusualProvisions	-277000	USD
CY2017	us-gaap	Tax Adjustments Settlements And Unusual Provisions TaxAdjustmentsSettlementsAndUnusualProvisions	0	USD
CY2016Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	5135000	USD
CY2017Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	6711000	USD
CY2016	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	37.36
CY2016	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	42.39
CY2017	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	84.90
CY2016Q1	us-gaap	Treasury Stock Shares TreasuryStockShares	14255000	shares
CY2016Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	15059000	shares
CY2016	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	4148000	shares
CY2016	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	1496000	shares
CY2017	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	804000	shares
CY2016Q4	us-gaap	Treasury Stock Value TreasuryStockValue	404276000	USD
CY2017Q4	us-gaap	Treasury Stock Value TreasuryStockValue	472536000	USD
CY2016	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	154967000	USD
CY2016	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	63402000	USD
CY2017	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	68260000	USD
CY2017Q4	us-gaap	Undistributed Earnings Of Foreign Subsidiaries UndistributedEarningsOfForeignSubsidiaries	37400000	USD
CY2016Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	8875000	USD
CY2016Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	14494000	USD
CY2017Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	16157000	USD
CY2016	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	296000	USD
CY2017	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	0	USD
CY2016Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	1200000	USD
CY2017Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	1600000	USD
CY2016	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	200000	USD
CY2016	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	100000	USD
CY2017	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	300000	USD
CY2016	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	6437000	USD
CY2017	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	2142000	USD
CY2016	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	143000	USD
CY2017	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	498000	USD
CY2016	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	388000	USD
CY2017	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	977000	USD
CY2016	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	53707000	shares
CY2016	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	53195000	shares
CY2017	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	55874000	shares
CY2016	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	51311000	shares
CY2016	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	49530000	shares
CY2017	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	51516000	shares
CY2017	us-gaap	Fiscal Period FiscalPeriod	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:17px;text-indent:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Fiscal Periods</font></div><div style="line-height:120%;padding-top:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company follows a conventional 52/53 week fiscal year. Under a conventional 52/53 week fiscal year, a 52 week fiscal year includes four quarters of 13 weeks while a 53 week fiscal year includes three quarters of 13 weeks and one quarter of 14 weeks. The Company’s last 53 week fiscal year was fiscal year 2014. Fiscal years 2015, 2016 and 2017 were 52 week fiscal years. All references to years in these notes to consolidated financial statements are fiscal years unless otherwise noted.</font></div></div>
CY2017	us-gaap	Nature Of Operations NatureOfOperations	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Description of the Company</font></div><div style="line-height:120%;padding-top:6px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Masimo Corporation (the Company), is a global medical technology company that develops, manufactures and markets a variety of noninvasive monitoring technologies. The Company’s mission is to improve patient outcomes and reduce the cost of care. The Company’s patient monitoring solutions generally incorporate a monitor or circuit board, proprietary single-patient-use, reusable or resposable sensors, software and/or cables. The Company primarily sells its products to hospitals, emergency medical service (EMS) providers, home care providers, physician offices, veterinarians, long-term care facilities and consumers through its direct sales force, distributors and original equipment manufacturer (OEM) partners.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company invented Masimo Signal Extraction Technology</font><font style="font-family:inherit;font-size:7pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">® </sup></font><font style="font-family:inherit;font-size:10pt;">(SET</font><font style="font-family:inherit;font-size:7pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">®</sup></font><font style="font-family:inherit;font-size:10pt;">), which provides the capabilities of </font><font style="font-family:inherit;font-size:10pt;">Measure-through Motion and Low Perfusion</font><font style="font-family:inherit;font-size:7pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">®</sup></font><font style="font-family:inherit;font-size:10pt;"> pulse oximetry to address the primary limitations of conventional pulse oximetry. Over the years, the Company’s product offerings have expanded significantly to also include rainbow</font><font style="font-family:inherit;font-size:7pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">®</sup></font><font style="font-family:inherit;font-size:10pt;"> Pulse CO-Oximetry, with its ability to measure and monitor carboxyhemoglobin (SpCO</font><font style="font-family:inherit;font-size:7pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">®</sup></font><font style="font-family:inherit;font-size:10pt;">), methemoglobin (SpMet</font><font style="font-family:inherit;font-size:7pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">®</sup></font><font style="font-family:inherit;font-size:10pt;">), total hemoglobin concentration (SpHb</font><font style="font-family:inherit;font-size:7pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">®</sup></font><font style="font-family:inherit;font-size:10pt;">), fractional arterial oxygen saturation (SpfO</font><font style="font-family:inherit;font-size:10pt;"><sub style="vertical-align:bottom;line-height:120%;font-size:7pt">2</sub></font><font style="font-family:inherit;font-size:7pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">™</sup></font><font style="font-family:inherit;font-size:10pt;">), Oxygen Content (SpOC</font><font style="font-family:inherit;font-size:7pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">™</sup></font><font style="font-family:inherit;font-size:10pt;">), Pleth Variability Index (PVi</font><font style="font-family:inherit;font-size:7pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">®</sup></font><font style="font-family:inherit;font-size:10pt;">), rainbow</font><font style="font-family:inherit;font-size:7pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">®</sup></font><font style="font-family:inherit;font-size:10pt;"> Pleth Variability Index (RPVi</font><font style="font-family:inherit;font-size:7pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">™</sup></font><font style="font-family:inherit;font-size:10pt;">), respiration rate from the pleth (RRp</font><font style="font-family:inherit;font-size:7pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">®</sup></font><font style="font-family:inherit;font-size:10pt;"> and Oxygen Reserve Index (ORi</font><font style="font-family:inherit;font-size:7pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">™</sup></font><font style="font-family:inherit;font-size:10pt;">); acoustic respiration monitoring (RRa</font><font style="font-family:inherit;font-size:7pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">®</sup></font><font style="font-family:inherit;font-size:10pt;">), electrical brain function monitoring (SedLine</font><font style="font-family:inherit;font-size:7pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">®</sup></font><font style="font-family:inherit;font-size:10pt;">), and optical gas monitoring. The Company also developed the Root</font><font style="font-family:inherit;font-size:7pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">™</sup></font><font style="font-family:inherit;font-size:10pt;"> patient monitoring and connectivity platform and the Masimo Patient SafetyNet remote patient surveillance monitoring system. These solutions and related products are based upon Masimo SET</font><font style="font-family:inherit;font-size:7pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">®</sup></font><font style="font-family:inherit;font-size:10pt;">, rainbow</font><font style="font-family:inherit;font-size:7pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">®</sup></font><font style="font-family:inherit;font-size:10pt;"> and other proprietary algorithms. These software-based technologies are incorporated into a variety of product platforms depending on customers’ specifications. This technology is supported by a substantial intellectual property portfolio that the Company has built through internal development and, to a lesser extent, acquisitions and license agreements.</font></div></div>
CY2017	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:17px;text-align:left;padding-left:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Reclassifications </font></div><div style="line-height:120%;padding-top:6px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain amounts in the consolidated financial statements for prior periods have been reclassified to conform to current period presentation. </font></div></div>
CY2017	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:17px;text-indent:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-top:6px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company prepares its financial statements in conformity with GAAP, which requires the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Significant estimates include the determination of accounts receivable allowances, inventory reserves, warranty reserves, rebate accruals, valuation of the Company’s stock awards, goodwill valuation, deferred taxes and any associated valuation allowances, tax impact of the distributor channel inventory, royalty revenues, deferred revenue, uncertain income tax positions, litigation costs and loss contingency accruals. In addition, for the year ended </font><font style="font-family:inherit;font-size:10pt;">December 30, 2017</font><font style="font-family:inherit;font-size:10pt;">, certain estimates were made in calculating the provision for income taxes related to the impact of the Tax Cuts and Jobs Act of 2017 (2017 Tax Act) that was signed into law on December 22, 2017. Actual results could differ from the Company’s estimates.</font></div></div>

Files In Submission

Name	View Source	Status
0000937556-18-000019-index-headers.html	Edgar Link	pending
0000937556-18-000019-index.html	Edgar Link	pending
0000937556-18-000019.txt	Edgar Link	pending
0000937556-18-000019-xbrl.zip	Edgar Link	pending
a3798rainbowdciminisc4003q82.jpg	Edgar Link	pending
a4042rdrainbowliteset1adt.jpg	Edgar Link	pending
a40parkerlogo.jpg	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
irisconnectivitygraphic.jpg	Edgar Link	pending
irisintregrationa02.jpg	Edgar Link	pending
irisport.jpg	Edgar Link	pending
ispo23.jpg	Edgar Link	pending
ispo2pulseoximeterlightca02.jpg	Edgar Link	pending
masi-20171230.xml	Edgar Link	completed
masi-20171230.xsd	Edgar Link	pending
masi-20171230x10kex121.htm	Edgar Link	pending
masi-20171230x10kex211.htm	Edgar Link	pending
masi-20171230x10kex311.htm	Edgar Link	pending
masi-20171230x10kex312.htm	Edgar Link	pending
masi-20171230x10kex321.htm	Edgar Link	pending
masi-20171230x10xkex1016.htm	Edgar Link	pending
masi-20171230xform10k.htm	Edgar Link	pending
masi-20171230_cal.xml	Edgar Link	unprocessable
masi-20171230_def.xml	Edgar Link	unprocessable
masi-20171230_lab.xml	Edgar Link	unprocessable
masi-20171230_pre.xml	Edgar Link	unprocessable
masi-2017x1230x10kex231.htm	Edgar Link	pending
masi20150102charta03.jpg	Edgar Link	pending
masimologo300pra03.jpg	Edgar Link	pending
mightysatrxa01.jpg	Edgar Link	pending
mx3boarda03.jpg	Edgar Link	pending
mx5.jpg	Edgar Link	pending
mx7msx.jpg	Edgar Link	pending
nomolinegroup311018.jpg	Edgar Link	pending
psnsystema01.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
rad973upgroup91117.jpg	Edgar Link	pending
rad97isa3qlt3upus91117a01.jpg	Edgar Link	pending
radical7combofront1a04.jpg	Edgar Link	pending
radius7a06.jpg	Edgar Link	pending
rainbowseta03.jpg	Edgar Link	pending
report.css	Edgar Link	pending
rootwithanalogviewa06.jpg	Edgar Link	pending
rootwithbloodprestemp.jpg	Edgar Link	pending
sedlinesensora01.jpg	Edgar Link	pending
Show.js	Edgar Link	pending
tfa1sensor2a01.jpg	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MASI
MASIMO CORP Stock $masi

2017 Q4 Form 10-K Financial Statement

#000093755618000019 Filed on February 28, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MASI MASIMO CORP Stock $masi

2017 Q4 Form 10-K Financial Statement

#000093755618000019 Filed on February 28, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MASI
MASIMO CORP Stock $masi